title: Chronic hypernatremia derived from hypothalamic dysfunction: impaired secretion of arginine vasopressin and enhanced renal water handling.
abstract: We analyzed the disorder of water metabolism in a 32 year-old female with chronic hypernatremia. She had meningitis at 4 years, and ventriculo-peritoneal shunt operation at 13 years because of normal pressure hydrocephalus. At 14 years hypernatremia of 166 mmol/l was initially found and thereafter hypernatremia ranging from 150 to 166 mmol/l has been persisted for the last 18 years. Physical and laboratory findings did not show dehydration. Urine volume was 750-1700 ml per day and urinary osmolality (Uosm) 446-984 mmol/kg, suggesting no urinary concentrating defect. Plasma arginine vasopressin (AVP) levels ranged from 0.4 to 1.2 pmol/l despite hyperosmolality of 298 through 343 mmol/kg under ad libitum water drinking. There was no correlation between plasma osmolality (Posm) and plasma AVP levels, but Uosm had a positive correlation with Posm (r=0.545, P < 0.05). Hypertonic saline (500 NaCl) infusion after a water load increased Uosm from 377 to 679 mmol/kg, and plasma AVP from 0.2 to 1.3 pmol/l. There was a positive correlation between Posm and plasma AVP levels in the hypertonic saline test (r=0.612, P<0.05). In contrast, an acute water load (20 ml/kg BW) verified the presence of impaired water excretion, as the percent excretion of the water load was only 8.5% and the minimal Uosm was as high as 710 mmol/kg. Urinary excretion of aquaporin-2 remained low in concert with plasma AVP levels. No abnormality in pituitary-adrenocortical function was found. These results indicate that marked hypernatremia is derived from partial central diabetes insipidus and elevated threshold of thirst, and that enhanced renal water handling may contribute to maintenance of body water in the present subject.
authors.affiliation: Department of Medicine, Jichi Medical School, Tochigi, Japan.
authors.forename: A
authors.initials: A
authors.lastname: Fukagawa
authors.forename: S E
authors.initials: SE
authors.lastname: Ishikawa
authors.forename: T
authors.initials: T
authors.lastname: Saito
authors.forename: I
authors.initials: I
authors.lastname: Kusaka
authors.forename: T
authors.initials: T
authors.lastname: Nakamura
authors.forename: M
authors.initials: M
authors.lastname: Higashiyama
authors.forename: S
authors.initials: S
authors.lastname: Nagasaka
authors.forename: G
authors.initials: G
authors.lastname: Kusaka
authors.forename: T
authors.initials: T
authors.lastname: Masuzawa
authors.forename: T
authors.initials: T
authors.lastname: Saito
mesh_terms: D000328:Adult; D051399:Aquaporin 2; D051403:Aquaporin 6; D020346:Aquaporins / Q000652:urine; D001127:Arginine Vasopressin / Q000378:metabolism*; D001769:Blood; D001834:Body Water / Q000378:metabolism*; D002908:Chronic Disease; D003919:Diabetes Insipidus / Q000150:complications* / Q000175:diagnosis / Q000503:physiopathology; D004231:Diuresis; D005260:Female; D006801:Humans; D006850:Hydrocephalus, Normal Pressure / Q000150:complications / Q000601:surgery; D006955:Hypernatremia / Q000209:etiology*; D007031:Hypothalamus / Q000503:physiopathology*; D007668:Kidney / Q000378:metabolism*; D008279:Magnetic Resonance Imaging; D008581:Meningitis / Q000150:complications; D009994:Osmolar Concentration; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage; D013894:Thirst; D014556:Urine; D017287:Ventriculoperitoneal Shunt; D014867:Water
chemical_list: C496023:AQP2 protein, human; D051399:Aquaporin 2; D051403:Aquaporin 6; D020346:Aquaporins; D012462:Saline Solution, Hypertonic; D014867:Water; D001127:Arginine Vasopressin